Back to results
CompletedPhase 3

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

NCT00053599

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama, Birmingham

Birmingham, Alabama, United States

+43 additional locations

View on ClinicalTrials.gov
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study — TrialFind